| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | inhibitory MHC class I receptor activity | 4.70e-05 | 12 | 122 | 3 | GO:0032396 | |
| GeneOntologyMolecularFunction | protein phosphatase 1 binding | 6.00e-05 | 35 | 122 | 4 | GO:0008157 | |
| GeneOntologyMolecularFunction | MHC class I receptor activity | 1.70e-04 | 18 | 122 | 3 | GO:0032393 | |
| GeneOntologyMolecularFunction | protein kinase binding | SPDYE17 TPCN2 SPDYE10 DSCAM INSR SPDYE12 GRM5 PPP1CB PPP1CC SPDYE11 SPDYE15 SPDYE3 IRAK4 SPDYE8 SPDYE14 | 2.83e-04 | 873 | 122 | 15 | GO:0019901 |
| GeneOntologyMolecularFunction | HLA-A specific inhibitory MHC class I receptor activity | 3.66e-04 | 5 | 122 | 2 | GO:0030107 | |
| GeneOntologyMolecularFunction | cell-cell adhesion mediator activity | 5.29e-04 | 61 | 122 | 4 | GO:0098632 | |
| GeneOntologyMolecularFunction | immune receptor activity | 5.33e-04 | 165 | 122 | 6 | GO:0140375 | |
| GeneOntologyMolecularFunction | HLA-B specific inhibitory MHC class I receptor activity | 5.47e-04 | 6 | 122 | 2 | GO:0030109 | |
| GeneOntologyMolecularFunction | potassium channel activator activity | 5.47e-04 | 6 | 122 | 2 | GO:0099104 | |
| GeneOntologyMolecularFunction | MHC class Ib protein complex binding | 7.62e-04 | 7 | 122 | 2 | GO:0023025 | |
| GeneOntologyMolecularFunction | kinase binding | SPDYE17 TPCN2 SPDYE10 DSCAM INSR SPDYE12 GRM5 PPP1CB PPP1CC SPDYE11 SPDYE15 SPDYE3 IRAK4 SPDYE8 SPDYE14 | 8.38e-04 | 969 | 122 | 15 | GO:0019900 |
| GeneOntologyMolecularFunction | tRNA-specific adenosine deaminase activity | 1.01e-03 | 8 | 122 | 2 | GO:0008251 | |
| GeneOntologyMolecularFunction | cell adhesion mediator activity | 1.21e-03 | 76 | 122 | 4 | GO:0098631 | |
| GeneOntologyMolecularFunction | histone H4K16 acetyltransferase activity | 1.30e-03 | 9 | 122 | 2 | GO:0046972 | |
| GeneOntologyMolecularFunction | histone H3K14 acetyltransferase activity | 1.30e-03 | 9 | 122 | 2 | GO:0036408 | |
| GeneOntologyMolecularFunction | channel activator activity | 1.61e-03 | 10 | 122 | 2 | GO:0099103 | |
| GeneOntologyMolecularFunction | myosin phosphatase activity | 1.83e-03 | 85 | 122 | 4 | GO:0017018 | |
| GeneOntologyMolecularFunction | protein phosphatase binding | 1.85e-03 | 210 | 122 | 6 | GO:0019903 | |
| GeneOntologyMolecularFunction | histone H4K8 acetyltransferase activity | 1.96e-03 | 11 | 122 | 2 | GO:0043996 | |
| GeneOntologyMolecularFunction | histone H4K5 acetyltransferase activity | 1.96e-03 | 11 | 122 | 2 | GO:0043995 | |
| GeneOntologyMolecularFunction | IgM binding | 1.96e-03 | 11 | 122 | 2 | GO:0001791 | |
| GeneOntologyMolecularFunction | transporter activator activity | 2.35e-03 | 12 | 122 | 2 | GO:0141109 | |
| GeneOntologyMolecularFunction | histone H4K12 acetyltransferase activity | 2.35e-03 | 12 | 122 | 2 | GO:0043997 | |
| GeneOntologyBiologicalProcess | cytokine-mediated signaling pathway | EPOR XCR1 LILRA1 LILRA3 TUT4 MUC19 IL20RA LILRB1 STAT5A STAT5B LRP8 GH1 EDAR IRAK4 USP27X | 6.07e-07 | 577 | 113 | 15 | GO:0019221 |
| GeneOntologyBiologicalProcess | interleukin-10-mediated signaling pathway | 2.56e-05 | 11 | 113 | 3 | GO:0140105 | |
| GeneOntologyBiologicalProcess | natural killer cell differentiation | 5.46e-05 | 38 | 113 | 4 | GO:0001779 | |
| GeneOntologyBiologicalProcess | positive regulation of gamma-delta T cell activation | 5.58e-05 | 14 | 113 | 3 | GO:0046645 | |
| GeneOntologyBiologicalProcess | cellular response to cytokine stimulus | EPOR XCR1 LILRA1 LILRA3 TUT4 MUC19 IL20RA LILRB1 STAT5A STAT5B LRP8 GH1 EDAR IRAK4 ABCD4 USP27X | 7.44e-05 | 967 | 113 | 16 | GO:0071345 |
| GeneOntologyBiologicalProcess | response to cytokine | EPOR XCR1 LILRA1 LILRA3 TUT4 INSR MUC19 IL20RA LILRB1 STAT5A STAT5B LRP8 GH1 EDAR IRAK4 ABCD4 USP27X | 8.30e-05 | 1083 | 113 | 17 | GO:0034097 |
| GeneOntologyBiologicalProcess | development of secondary male sexual characteristics | 8.89e-05 | 3 | 113 | 2 | GO:0046544 | |
| GeneOntologyBiologicalProcess | response to peptide | EPOR XCR1 LILRA1 LILRA3 TUT4 INSR MUC19 IL20RA LILRB1 STAT5A STAT5B LRP8 GH1 EDAR IRAK4 ABCD4 USP27X | 1.00e-04 | 1100 | 113 | 17 | GO:1901652 |
| GeneOntologyBiologicalProcess | regulation of gamma-delta T cell activation | 1.03e-04 | 17 | 113 | 3 | GO:0046643 | |
| GeneOntologyBiologicalProcess | rhythmic process | 1.65e-04 | 360 | 113 | 9 | GO:0048511 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell differentiation | 1.98e-04 | 21 | 113 | 3 | GO:0032823 | |
| GeneOntologyBiologicalProcess | glycogen metabolic process | 2.14e-04 | 99 | 113 | 5 | GO:0005977 | |
| GeneOntologyBiologicalProcess | glucan metabolic process | 2.35e-04 | 101 | 113 | 5 | GO:0044042 | |
| GeneOntologyCellularComponent | PTW/PP1 phosphatase complex | 5.59e-06 | 7 | 115 | 3 | GO:0072357 | |
| GeneOntologyCellularComponent | protein phosphatase type 1 complex | 1.47e-04 | 19 | 115 | 3 | GO:0000164 | |
| Domain | IGc2 | PRTG LILRA1 LILRA3 IGFN1 SDK2 DSCAM MYOM3 NFASC LILRB1 HMCN1 ICAM5 | 1.87e-07 | 235 | 113 | 11 | SM00408 |
| Domain | Ig_sub2 | PRTG LILRA1 LILRA3 IGFN1 SDK2 DSCAM MYOM3 NFASC LILRB1 HMCN1 ICAM5 | 1.87e-07 | 235 | 113 | 11 | IPR003598 |
| Domain | STPPase_N | 2.16e-07 | 3 | 113 | 3 | IPR031675 | |
| Domain | STPPase_N | 2.16e-07 | 3 | 113 | 3 | PF16891 | |
| Domain | Ig-like_fold | EPOR PRTG LILRA1 POGLUT3 LILRA3 IGFN1 SDK2 DSCAM INSR MYOM3 TMIGD3 IL20RA NFASC LILRB1 HMCN1 IGHD ICAM5 CD48 | 2.34e-07 | 706 | 113 | 18 | IPR013783 |
| Domain | ig | LILRA1 LILRA3 SDK2 DSCAM MYOM3 NFASC LILRB1 HMCN1 IGHD ICAM5 | 2.35e-07 | 190 | 113 | 10 | PF00047 |
| Domain | Immunoglobulin | LILRA1 LILRA3 SDK2 DSCAM MYOM3 NFASC LILRB1 HMCN1 IGHD ICAM5 | 2.35e-07 | 190 | 113 | 10 | IPR013151 |
| Domain | - | EPOR PRTG LILRA1 POGLUT3 LILRA3 IGFN1 SDK2 DSCAM INSR MYOM3 TMIGD3 IL20RA NFASC LILRB1 HMCN1 ICAM5 CD48 | 4.86e-07 | 663 | 113 | 17 | 2.60.40.10 |
| Domain | Ig-like_dom | PRTG LILRA1 LILRA3 IGFN1 SDK2 DSCAM MYOM3 TMIGD3 NFASC LILRB1 HMCN1 IGHD ICAM5 CD48 | 2.11e-06 | 503 | 113 | 14 | IPR007110 |
| Domain | FN3 | 3.39e-06 | 199 | 113 | 9 | PS50853 | |
| Domain | FN3_dom | 5.06e-06 | 209 | 113 | 9 | IPR003961 | |
| Domain | fn3 | 6.37e-06 | 162 | 113 | 8 | PF00041 | |
| Domain | IG_LIKE | PRTG LILRA1 LILRA3 IGFN1 SDK2 DSCAM MYOM3 NFASC LILRB1 HMCN1 IGHD ICAM5 CD48 | 8.57e-06 | 491 | 113 | 13 | PS50835 |
| Domain | IG | PRTG LILRA1 LILRA3 IGFN1 SDK2 DSCAM MYOM3 NFASC LILRB1 HMCN1 ICAM5 CD48 | 9.33e-06 | 421 | 113 | 12 | SM00409 |
| Domain | Ig_sub | PRTG LILRA1 LILRA3 IGFN1 SDK2 DSCAM MYOM3 NFASC LILRB1 HMCN1 ICAM5 CD48 | 9.33e-06 | 421 | 113 | 12 | IPR003599 |
| Domain | FN3 | 1.68e-05 | 185 | 113 | 8 | SM00060 | |
| Domain | Ig_I-set | 2.04e-05 | 190 | 113 | 8 | IPR013098 | |
| Domain | I-set | 2.04e-05 | 190 | 113 | 8 | PF07679 | |
| Domain | Ser/Thr-sp_prot-phosphatase | 5.90e-05 | 13 | 113 | 3 | IPR006186 | |
| Domain | SER_THR_PHOSPHATASE | 5.90e-05 | 13 | 113 | 3 | PS00125 | |
| Domain | PP2Ac | 5.90e-05 | 13 | 113 | 3 | SM00156 | |
| Domain | Ig_2 | 8.03e-05 | 73 | 113 | 5 | PF13895 | |
| Domain | ADEAMc | 5.36e-04 | 6 | 113 | 2 | SM00552 | |
| Domain | A_deamin | 5.36e-04 | 6 | 113 | 2 | PF02137 | |
| Domain | A_DEAMIN_EDITASE | 5.36e-04 | 6 | 113 | 2 | PS50141 | |
| Domain | A1B_glyco/leuk_Ig-like_rcpt | 5.36e-04 | 6 | 113 | 2 | IPR016332 | |
| Domain | A_deamin | 5.36e-04 | 6 | 113 | 2 | IPR002466 | |
| Domain | Calcineurin-like_PHP_ApaH | 6.33e-04 | 28 | 113 | 3 | IPR004843 | |
| Domain | Metallophos | 6.33e-04 | 28 | 113 | 3 | PF00149 | |
| Domain | STAT_TF_prot_interaction | 7.47e-04 | 7 | 113 | 2 | IPR013799 | |
| Domain | STAT_TF_DNA-bd_sub | 7.47e-04 | 7 | 113 | 2 | IPR012345 | |
| Domain | STAT | 7.47e-04 | 7 | 113 | 2 | IPR001217 | |
| Domain | STAT_TF_coiled-coil | 7.47e-04 | 7 | 113 | 2 | IPR015988 | |
| Domain | - | 7.47e-04 | 7 | 113 | 2 | 2.60.40.630 | |
| Domain | STAT_int | 7.47e-04 | 7 | 113 | 2 | SM00964 | |
| Domain | STAT_TF_DNA-bd | 7.47e-04 | 7 | 113 | 2 | IPR013801 | |
| Domain | STAT_bind | 7.47e-04 | 7 | 113 | 2 | PF02864 | |
| Domain | STAT_int | 7.47e-04 | 7 | 113 | 2 | PF02865 | |
| Domain | - | 7.47e-04 | 7 | 113 | 2 | 1.10.532.10 | |
| Domain | STAT_alpha | 7.47e-04 | 7 | 113 | 2 | PF01017 | |
| Domain | - | 7.47e-04 | 7 | 113 | 2 | 1.20.1050.20 | |
| Domain | Metallo-depent_PP-like | 7.77e-04 | 30 | 113 | 3 | IPR029052 | |
| Domain | - | 7.77e-04 | 30 | 113 | 3 | 3.60.21.10 | |
| Domain | EPL1 | 9.92e-04 | 8 | 113 | 2 | PF10513 | |
| Domain | STAT_TF_alpha | 9.92e-04 | 8 | 113 | 2 | IPR013800 | |
| Domain | Enhancer_polycomb-like_N | 9.92e-04 | 8 | 113 | 2 | IPR019542 | |
| Domain | Carbonic_anhydrase_a-class_CS | 2.30e-03 | 12 | 113 | 2 | IPR018338 | |
| Domain | - | 2.88e-03 | 47 | 113 | 3 | 3.30.420.10 | |
| Domain | Carbonic_anhydrase_a-class | 3.62e-03 | 15 | 113 | 2 | IPR023561 | |
| Domain | ALPHA_CA_1 | 3.62e-03 | 15 | 113 | 2 | PS00162 | |
| Domain | ALPHA_CA_2 | 4.65e-03 | 17 | 113 | 2 | PS51144 | |
| Domain | Carb_anhydrase | 4.65e-03 | 17 | 113 | 2 | PF00194 | |
| Domain | Carb_anhydrase | 4.65e-03 | 17 | 113 | 2 | SM01057 | |
| Domain | - | 4.65e-03 | 17 | 113 | 2 | 3.10.200.10 | |
| Domain | Carbonic_anhydrase_a | 4.65e-03 | 17 | 113 | 2 | IPR001148 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HORMONE_LIKE_CYTOKINE_TO_JAK_STAT_SIGNALING_PATHWAY | 2.27e-06 | 17 | 81 | 4 | M47905 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GH_JAK_STAT_SIGNALING_PATHWAY | 6.29e-06 | 7 | 81 | 3 | M47646 | |
| Pathway | REACTOME_ERYTHROPOIETIN_ACTIVATES_STAT5 | 6.29e-06 | 7 | 81 | 3 | M27907 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_MRAS_SHOC2_PP1_HOLOPHOSPHATASE | 1.00e-05 | 8 | 81 | 3 | M47933 | |
| Pathway | BIOCARTA_GH_PATHWAY | 1.61e-05 | 27 | 81 | 4 | M9043 | |
| Pathway | BIOCARTA_GH_PATHWAY | 3.65e-05 | 33 | 81 | 4 | MM1404 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CENPE_INTERACTION_WITH_NDC80_COMPLEX | 3.87e-05 | 12 | 81 | 3 | M47887 | |
| Pathway | KEGG_MEDICUS_REFERENCE_DEPHOSPHORYLATION_OF_KINETOCHORE | 3.87e-05 | 12 | 81 | 3 | M47891 | |
| Pathway | WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS | 4.11e-05 | 34 | 81 | 4 | M48081 | |
| Pathway | REACTOME_PROLACTIN_RECEPTOR_SIGNALING | 7.91e-05 | 15 | 81 | 3 | M552 | |
| Pathway | WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION | 8.71e-05 | 41 | 81 | 4 | M39655 | |
| Pathway | REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_RSV_GENOME_REPLICATION_TRANSCRIPTION_AND_TRANSLATION | 9.70e-05 | 16 | 81 | 3 | M48235 | |
| Pathway | REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING | 9.70e-05 | 16 | 81 | 3 | MM15710 | |
| Pathway | BIOCARTA_EPO_PATHWAY | 1.66e-04 | 19 | 81 | 3 | M12836 | |
| Pathway | REACTOME_INTERLEUKIN_20_FAMILY_SIGNALING | 1.94e-04 | 20 | 81 | 3 | MM15496 | |
| Pathway | BIOCARTA_EPO_PATHWAY | 1.94e-04 | 20 | 81 | 3 | MM1389 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_JAK_STAT_SIGNALING_PATHWAY | 3.22e-04 | 5 | 81 | 2 | M48987 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_JAK_STAT_SIGNALING_PATHWAY | 3.22e-04 | 5 | 81 | 2 | M48986 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PRL_JAK_STAT_SIGNALING_PATHWAY | 3.22e-04 | 5 | 81 | 2 | M49006 | |
| Pathway | REACTOME_TRIGLYCERIDE_CATABOLISM | 3.39e-04 | 24 | 81 | 3 | M10064 | |
| Pathway | REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING | 3.39e-04 | 24 | 81 | 3 | M519 | |
| Pathway | REACTOME_SIGNALING_BY_ERYTHROPOIETIN | 3.84e-04 | 25 | 81 | 3 | M27865 | |
| Pathway | REACTOME_INTERLEUKIN_20_FAMILY_SIGNALING | 4.32e-04 | 26 | 81 | 3 | M27750 | |
| Pathway | REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING | 4.32e-04 | 26 | 81 | 3 | M628 | |
| Pathway | WP_EPO_RECEPTOR_SIGNALING | 4.32e-04 | 26 | 81 | 3 | M39687 | |
| Pathway | WP_EPO_RECEPTOR_SIGNALING | 4.32e-04 | 26 | 81 | 3 | MM15896 | |
| Pathway | KEGG_OOCYTE_MEIOSIS | 4.78e-04 | 113 | 81 | 5 | M16817 | |
| Pathway | REACTOME_INTERLEUKIN_9_SIGNALING | 4.82e-04 | 6 | 81 | 2 | MM15581 | |
| Pathway | REACTOME_INTERLEUKIN_21_SIGNALING | 4.82e-04 | 6 | 81 | 2 | MM15621 | |
| Pathway | WP_AGERAGE_PATHWAY | 5.56e-04 | 66 | 81 | 4 | M39420 | |
| Pathway | REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY | 6.29e-04 | 120 | 81 | 5 | M48233 | |
| Pathway | REACTOME_STAT5_ACTIVATION | 6.72e-04 | 7 | 81 | 2 | M27953 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_JAK_STAT_SIGNALING_PATHWAY | 6.72e-04 | 7 | 81 | 2 | M47581 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_JAK_STAT_SIGNALING_PATHWAY | 6.72e-04 | 7 | 81 | 2 | M47430 | |
| Pathway | KEGG_LONG_TERM_POTENTIATION | 6.95e-04 | 70 | 81 | 4 | M3115 | |
| Pathway | PID_EPO_PATHWAY | 8.81e-04 | 33 | 81 | 3 | M233 | |
| Pathway | REACTOME_SIGNALING_BY_MRAS_COMPLEX_MUTANTS | 8.93e-04 | 8 | 81 | 2 | M38999 | |
| Pathway | REACTOME_INTERLEUKIN_9_SIGNALING | 1.14e-03 | 9 | 81 | 2 | M27861 | |
| Pathway | BIOCARTA_IL22BP_PATHWAY | 1.14e-03 | 9 | 81 | 2 | MM1419 | |
| Pathway | BIOCARTA_IL22BP_PATHWAY | 1.14e-03 | 9 | 81 | 2 | M8066 | |
| Pathway | WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING | 1.26e-03 | 140 | 81 | 5 | M42572 | |
| Pathway | REACTOME_TRIGLYCERIDE_METABOLISM | 1.33e-03 | 38 | 81 | 3 | M27856 | |
| Pathway | REACTOME_INTERLEUKIN_21_SIGNALING | 1.42e-03 | 10 | 81 | 2 | M27898 | |
| Pathway | REACTOME_STAT5_ACTIVATION_DOWNSTREAM_OF_FLT3_ITD_MUTANTS | 1.42e-03 | 10 | 81 | 2 | M41731 | |
| Pathway | REACTOME_INTERLEUKIN_2_SIGNALING | 1.42e-03 | 10 | 81 | 2 | MM15618 | |
| Pathway | REACTOME_SIGNALING_BY_LEPTIN | 1.73e-03 | 11 | 81 | 2 | M27195 | |
| Pathway | REACTOME_INTERLEUKIN_15_SIGNALING | 1.73e-03 | 11 | 81 | 2 | MM15578 | |
| Pathway | PID_TCPTP_PATHWAY | 1.79e-03 | 42 | 81 | 3 | M91 | |
| Pathway | KEGG_JAK_STAT_SIGNALING_PATHWAY | 1.97e-03 | 155 | 81 | 5 | M17411 | |
| Pathway | REACTOME_INTERLEUKIN_2_SIGNALING | 2.07e-03 | 12 | 81 | 2 | M27893 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CYTOKINE_JAK_STAT_SIGNALING_PATHWAY | 2.18e-03 | 45 | 81 | 3 | M47408 | |
| Pathway | WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION | 2.32e-03 | 46 | 81 | 3 | M39901 | |
| Pathway | WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4 | 2.44e-03 | 13 | 81 | 2 | M39582 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 2.47e-03 | 47 | 81 | 3 | M646 | |
| Pathway | REACTOME_INTERLEUKIN_15_SIGNALING | 2.84e-03 | 14 | 81 | 2 | M27858 | |
| Pathway | PID_IL5_PATHWAY | 2.84e-03 | 14 | 81 | 2 | M135 | |
| Pubmed | 4.32e-08 | 3 | 123 | 3 | 9122188 | ||
| Pubmed | 1E7-03, a low MW compound targeting host protein phosphatase-1, inhibits HIV-1 transcription. | 4.32e-08 | 3 | 123 | 3 | 25073485 | |
| Pubmed | Protein phosphatase 1 (PP1) is a post-translational regulator of the mammalian circadian clock. | 4.32e-08 | 3 | 123 | 3 | 21712997 | |
| Pubmed | Role of erythropoietin receptor signaling in Friend virus-induced erythroblastosis and polycythemia. | 4.32e-08 | 3 | 123 | 3 | 16174761 | |
| Pubmed | 4.32e-08 | 3 | 123 | 3 | 7857673 | ||
| Pubmed | Nuclear targeting of protein phosphatase-1 by HIV-1 Tat protein. | 1.72e-07 | 4 | 123 | 3 | 16131488 | |
| Pubmed | 1.72e-07 | 4 | 123 | 3 | 10194355 | ||
| Pubmed | Interaction between FGFR-2, STAT5, and progesterone receptors in breast cancer. | 1.72e-07 | 4 | 123 | 3 | 21464042 | |
| Pubmed | Stat5 activation enables erythropoiesis in the absence of EpoR and Jak2. | 1.72e-07 | 4 | 123 | 3 | 18239084 | |
| Pubmed | 1.72e-07 | 4 | 123 | 3 | 22768081 | ||
| Pubmed | 1.72e-07 | 4 | 123 | 3 | 8977232 | ||
| Pubmed | Nuclear protein phosphatase-1 regulates HIV-1 transcription. | 1.72e-07 | 4 | 123 | 3 | 12788939 | |
| Pubmed | 1.72e-07 | 4 | 123 | 3 | 21559424 | ||
| Pubmed | Protein phosphatase 1 inhibits p53 signaling by dephosphorylating and stabilizing Mdmx. | 1.72e-07 | 4 | 123 | 3 | 23277204 | |
| Pubmed | 1.72e-07 | 4 | 123 | 3 | 12226088 | ||
| Pubmed | N-CoR controls differentiation of neural stem cells into astrocytes. | 1.72e-07 | 4 | 123 | 3 | 12410313 | |
| Pubmed | HLA class I allelic sequence and conformation regulate leukocyte Ig-like receptor binding. | 1.72e-07 | 4 | 123 | 3 | 21270408 | |
| Pubmed | 4.29e-07 | 5 | 123 | 3 | 23197154 | ||
| Pubmed | 4.29e-07 | 5 | 123 | 3 | 12456798 | ||
| Pubmed | 4.29e-07 | 5 | 123 | 3 | 28615442 | ||
| Pubmed | Association of the type 1 protein phosphatase PP1 with the A-kinase anchoring protein AKAP220. | 4.29e-07 | 5 | 123 | 3 | 10209101 | |
| Pubmed | 4.29e-07 | 5 | 123 | 3 | 25487150 | ||
| Pubmed | 4.29e-07 | 5 | 123 | 3 | 20424263 | ||
| Pubmed | Epo receptor signaling in macrophages alters the splenic niche to promote erythroid differentiation. | 4.29e-07 | 5 | 123 | 3 | 32350523 | |
| Pubmed | 4.29e-07 | 5 | 123 | 3 | 12016208 | ||
| Pubmed | 4.29e-07 | 5 | 123 | 3 | 11551964 | ||
| Pubmed | The interaction of PP1 with BRCA1 and analysis of their expression in breast tumors. | 4.29e-07 | 5 | 123 | 3 | 17511879 | |
| Pubmed | SIPP1, a novel pre-mRNA splicing factor and interactor of protein phosphatase-1. | 8.57e-07 | 6 | 123 | 3 | 14640981 | |
| Pubmed | 8.57e-07 | 6 | 123 | 3 | 25785436 | ||
| Pubmed | 8.57e-07 | 6 | 123 | 3 | 21998301 | ||
| Pubmed | Protein phosphatase 1 regulates the phosphorylation state of the polarity scaffold Par-3. | 8.57e-07 | 6 | 123 | 3 | 18641122 | |
| Pubmed | 1.50e-06 | 7 | 123 | 3 | 12147701 | ||
| Pubmed | Inhibitor-2 prevents protein phosphatase 1-induced cardiac hypertrophy and mortality. | 1.50e-06 | 7 | 123 | 3 | 18689497 | |
| Pubmed | SARP, a new alternatively spliced protein phosphatase 1 and DNA interacting protein. | 1.50e-06 | 7 | 123 | 3 | 17123353 | |
| Pubmed | Contrasting dynamic responses in vivo of the Bcl-xL and Bim erythropoietic survival pathways. | 1.50e-06 | 7 | 123 | 3 | 22086418 | |
| Pubmed | 1.50e-06 | 7 | 123 | 3 | 22031092 | ||
| Pubmed | 2.39e-06 | 8 | 123 | 3 | 9548455 | ||
| Pubmed | 2.39e-06 | 8 | 123 | 3 | 21930935 | ||
| Pubmed | 2.39e-06 | 8 | 123 | 3 | 12036313 | ||
| Pubmed | 2.39e-06 | 8 | 123 | 3 | 16262633 | ||
| Pubmed | The SPOT technique as a tool for studying protein tyrosine phosphatase substrate specificities. | 3.57e-06 | 9 | 123 | 3 | 12237455 | |
| Pubmed | 3.57e-06 | 9 | 123 | 3 | 21566083 | ||
| Pubmed | 3.57e-06 | 9 | 123 | 3 | 15644415 | ||
| Pubmed | RRP1B targets PP1 to mammalian cell nucleoli and is associated with Pre-60S ribosomal subunits. | 3.57e-06 | 9 | 123 | 3 | 20926688 | |
| Pubmed | 3.57e-06 | 9 | 123 | 3 | 19417088 | ||
| Pubmed | 3.57e-06 | 9 | 123 | 3 | 19797429 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ANKRD13D POLE MYOM3 C15orf39 JADE1 EXTL3 ATG2A BIRC6 PLEKHM1 ARHGEF10L PCNX2 CASKIN1 CHPF HECTD1 ADAT1 | 8.81e-06 | 1105 | 123 | 15 | 35748872 |
| Pubmed | 9.28e-06 | 12 | 123 | 3 | 10830164 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 23151802 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 26999798 | ||
| Pubmed | Stat5 promotes metastatic behavior of human prostate cancer cells in vitro and in vivo. | 1.24e-05 | 2 | 123 | 2 | 20233708 | |
| Pubmed | Involvement of the STAT5 signaling pathway in the regulation of mouse preimplantation development. | 1.24e-05 | 2 | 123 | 2 | 16775227 | |
| Pubmed | Identification of Stat 5B as a substrate of the insulin receptor. | 1.24e-05 | 2 | 123 | 2 | 9428692 | |
| Pubmed | A Mouse Model to Assess STAT3 and STAT5A/B Combined Inhibition in Health and Disease Conditions. | 1.24e-05 | 2 | 123 | 2 | 31443474 | |
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 17447893 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 12377952 | ||
| Pubmed | A novel Ncr1-Cre mouse reveals the essential role of STAT5 for NK-cell survival and development. | 1.24e-05 | 2 | 123 | 2 | 21127177 | |
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 16289657 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 25552366 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 2544298 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 25470773 | ||
| Pubmed | Constitutively active Stat5A and Stat5B promote adipogenesis. | 1.24e-05 | 2 | 123 | 2 | 21431790 | |
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 16115927 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 23275557 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 28500076 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 21826656 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 8665851 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 11867689 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 7720707 | ||
| Pubmed | Global analysis of IL-2 target genes: identification of chromosomal clusters of expressed genes. | 1.24e-05 | 2 | 123 | 2 | 15980098 | |
| Pubmed | STAT5A and STAT5B have opposite correlations with drug response gene expression. | 1.24e-05 | 2 | 123 | 2 | 27264955 | |
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 15340066 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 22969412 | ||
| Pubmed | Protein phosphatase 1-dependent transcriptional programs for long-term memory and plasticity. | 1.24e-05 | 2 | 123 | 2 | 20592054 | |
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 22159083 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 31395656 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 11698424 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 20008792 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 33199496 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 30359304 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 10830280 | ||
| Pubmed | STAT5A/B gene locus undergoes amplification during human prostate cancer progression. | 1.24e-05 | 2 | 123 | 2 | 23660011 | |
| Pubmed | Role of Stat5 in type I interferon-signaling and transcriptional regulation. | 1.24e-05 | 2 | 123 | 2 | 12901872 | |
| Pubmed | PP-1α and PP-1γ display antagonism and differential roles in tumorigenicity of lung cancer cells. | 1.24e-05 | 2 | 123 | 2 | 23176181 | |
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 28074064 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 36755813 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 16502315 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 12217382 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 25333863 | ||
| Pubmed | A role for STAT5 in the pathogenesis of IL-2-induced glucocorticoid resistance. | 1.24e-05 | 2 | 123 | 2 | 12421978 | |
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 9852045 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 31599926 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 19966185 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 21704724 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 10594041 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 21036145 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 10486277 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 38618957 | ||
| Pubmed | Identification of human STAT5-dependent gene regulatory elements based on interspecies homology. | 1.24e-05 | 2 | 123 | 2 | 16840779 | |
| Pubmed | The role of the STAT5 proteins in the proliferation and apoptosis of the CML and AML cells. | 1.24e-05 | 2 | 123 | 2 | 15128421 | |
| Interaction | KIF18A interactions | 4.04e-07 | 52 | 111 | 6 | int:KIF18A | |
| Interaction | PPP1R2C interactions | 6.48e-07 | 4 | 111 | 3 | int:PPP1R2C | |
| Interaction | CSRNP2 interactions | 1.61e-06 | 5 | 111 | 3 | int:CSRNP2 | |
| Interaction | SFRP5 interactions | 3.21e-06 | 6 | 111 | 3 | int:SFRP5 | |
| Interaction | LILRA3 interactions | 2.60e-05 | 11 | 111 | 3 | int:LILRA3 | |
| Interaction | LILRA1 interactions | 3.01e-05 | 2 | 111 | 2 | int:LILRA1 | |
| Interaction | PPP1R2B interactions | 5.66e-05 | 14 | 111 | 3 | int:PPP1R2B | |
| Interaction | SNX17 interactions | 8.50e-05 | 81 | 111 | 5 | int:SNX17 | |
| Interaction | STAT5A interactions | 8.71e-05 | 131 | 111 | 6 | int:STAT5A | |
| Interaction | CUEDC2 interactions | 9.12e-05 | 43 | 111 | 4 | int:CUEDC2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q11 | SPDYE17 SPDYE10 SPDYE9 SPDYE12 SPDYE11 SPDYE13 SPDYE15 SPDYE8 SPDYE14 | 6.41e-08 | 271 | 125 | 9 | chr7q11 |
| Cytoband | 7q11.23 | 1.49e-04 | 97 | 125 | 4 | 7q11.23 | |
| Cytoband | 19p13.3-p13.2 | 6.55e-04 | 14 | 125 | 2 | 19p13.3-p13.2 | |
| Cytoband | 19q13.4 | 1.34e-03 | 79 | 125 | 3 | 19q13.4 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q21 | 1.94e-03 | 473 | 125 | 6 | chr17q21 | |
| Cytoband | 10q25.3 | 2.85e-03 | 29 | 125 | 2 | 10q25.3 | |
| Cytoband | 17q24.2 | 3.04e-03 | 30 | 125 | 2 | 17q24.2 | |
| Cytoband | 1p34 | 3.46e-03 | 32 | 125 | 2 | 1p34 | |
| Cytoband | 16q24.1 | 3.67e-03 | 33 | 125 | 2 | 16q24.1 | |
| GeneFamily | Fibronectin type III domain containing | 1.32e-06 | 160 | 90 | 8 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.57e-05 | 161 | 90 | 7 | 593 | |
| GeneFamily | Speedy/RINGO cell cycle regulator family | 2.54e-05 | 12 | 90 | 3 | 756 | |
| GeneFamily | Protein phosphatase catalytic subunits|EF-hand domain containing | 3.29e-05 | 13 | 90 | 3 | 693 | |
| GeneFamily | CD molecules|Activating leukocyte immunoglobulin like receptors | 3.63e-04 | 6 | 90 | 2 | 1181 | |
| GeneFamily | Adenosine deaminases acting on RNA | 6.73e-04 | 8 | 90 | 2 | 1303 | |
| GeneFamily | Ubiquitin specific peptidases | 2.73e-03 | 56 | 90 | 3 | 366 | |
| GeneFamily | Immunoglobulin like domain containing | 2.78e-03 | 193 | 90 | 5 | 594 | |
| GeneFamily | Carbonic anhydrases | 3.56e-03 | 18 | 90 | 2 | 460 | |
| GeneFamily | DNA polymerases | 5.79e-03 | 23 | 90 | 2 | 535 | |
| GeneFamily | Ankyrin repeat domain containing | 7.20e-03 | 242 | 90 | 5 | 403 | |
| Disease | glioblastoma (implicated_via_orthology) | 4.52e-06 | 9 | 113 | 3 | DOID:3068 (implicated_via_orthology) | |
| Disease | COVID-19 symptoms measurement | 3.27e-04 | 35 | 113 | 3 | EFO_0600019 | |
| Disease | colorectal cancer, hormone replacement therapy | 3.71e-04 | 88 | 113 | 4 | EFO_0003961, MONDO_0005575 | |
| Disease | Polycythemia | 4.01e-04 | 8 | 113 | 2 | C0032461 | |
| Disease | ductal carcinoma in situ (is_marker_for) | 4.52e-04 | 39 | 113 | 3 | DOID:0060074 (is_marker_for) | |
| Disease | Erythrocytosis | 5.14e-04 | 9 | 113 | 2 | C1527405 | |
| Disease | axin-2 measurement | 6.41e-04 | 10 | 113 | 2 | EFO_0801400 | |
| Disease | high grade glioma (implicated_via_orthology) | 6.46e-04 | 44 | 113 | 3 | DOID:3070 (implicated_via_orthology) | |
| Disease | Diabetic Asymmetric Polyneuropathy | 1.28e-03 | 14 | 113 | 2 | C0393835 | |
| Disease | Diabetic Neuralgia | 1.28e-03 | 14 | 113 | 2 | C0751074 | |
| Disease | Diabetic Neuropathies | 1.28e-03 | 14 | 113 | 2 | C0011882 | |
| Disease | anemia (is_implicated_in) | 1.28e-03 | 14 | 113 | 2 | DOID:2355 (is_implicated_in) | |
| Disease | Asymmetric Diabetic Proximal Motor Neuropathy | 1.28e-03 | 14 | 113 | 2 | C0271674 | |
| Disease | Symmetric Diabetic Proximal Motor Neuropathy | 1.28e-03 | 14 | 113 | 2 | C0271673 | |
| Disease | Diabetic Mononeuropathy | 1.28e-03 | 14 | 113 | 2 | C0271678 | |
| Disease | Diabetic Autonomic Neuropathy | 1.28e-03 | 14 | 113 | 2 | C0271686 | |
| Disease | Diabetic Amyotrophy | 1.28e-03 | 14 | 113 | 2 | C0271685 | |
| Disease | Diabetic Polyneuropathies | 1.28e-03 | 14 | 113 | 2 | C0271680 | |
| Disease | leukocyte immunoglobulin-like receptor subfamily B member 1 measurement | 1.48e-03 | 15 | 113 | 2 | EFO_0008208 | |
| Disease | hepatic encephalopathy (biomarker_via_orthology) | 1.48e-03 | 15 | 113 | 2 | DOID:13413 (biomarker_via_orthology) | |
| Disease | aggressive behaviour measurement, ADHD symptom measurement | 2.29e-03 | 68 | 113 | 3 | EFO_0007826, EFO_0007860 | |
| Disease | cognitive function measurement, self reported educational attainment | 2.50e-03 | 355 | 113 | 6 | EFO_0004784, EFO_0008354 | |
| Disease | estrogen-receptor negative breast cancer | 2.59e-03 | 71 | 113 | 3 | EFO_1000650 | |
| Disease | COVID-19, osteoarthritis | 2.64e-03 | 20 | 113 | 2 | MONDO_0005178, MONDO_0100096 | |
| Disease | Endometrial Carcinoma | 2.69e-03 | 72 | 113 | 3 | C0476089 | |
| Disease | cancer (implicated_via_orthology) | 3.77e-03 | 268 | 113 | 5 | DOID:162 (implicated_via_orthology) | |
| Disease | Alcoholic Intoxication, Chronic | 3.77e-03 | 268 | 113 | 5 | C0001973 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GVKPSLGIWTPEAIC | 611 | Q9BXT4 | |
| PVACSLGLSGEWVPT | 66 | Q8N616 | |
| TLGLPLELLECVSWP | 91 | Q8N976 | |
| LELLECVSWPLCGSP | 96 | Q8N976 | |
| SFTTPPCEECIVWLL | 196 | P07451 | |
| LLWECPVGDILPNSS | 101 | Q5H9S7 | |
| EPTPDTCRGLSLNWS | 476 | Q8NCV1 | |
| VLWDLESPPVCLTVG | 956 | Q9HCE6 | |
| NLCGCDEPLSSVWVP | 426 | Q6ZTN6 | |
| IPTCGDLASLSIDIW | 1806 | Q9NR09 | |
| LGLELPLSCQEVLWP | 26 | Q9P2X0 | |
| LGVLAVVCPDEWPLL | 661 | Q8IZ83 | |
| VVCPDEWPLLAFVSL | 666 | Q8IZ83 | |
| APWSALPCGLLLDEL | 361 | P0CJ87 | |
| VPSCETWVEAVLPEL | 376 | Q96NS5 | |
| PAPEWASINLGVTLC | 426 | Q15027 | |
| PSLSPAACWIDVLGR | 1631 | Q96M86 | |
| CEILGESEWGLDTPP | 361 | O14678 | |
| PESSWEPDECTLLSP | 221 | A6NLC5 | |
| EVLECLWPRGTSEPE | 521 | Q2TAZ0 | |
| LVPCGAAISWSAVPE | 391 | Q9BUB4 | |
| PDCLVIIWDSFTGIP | 321 | Q8TBY9 | |
| PATITIETCEDPGDW | 211 | Q9UKD1 | |
| LPEIAWISTLPFCGS | 156 | Q8NGY2 | |
| IGTASWSDPCLPELP | 591 | O60393 | |
| WKELGSPEGVLVCPS | 786 | Q504Q3 | |
| AAEISGLSIPDWLPE | 526 | Q8WXD9 | |
| SWPTDDLTGCDLIPV | 556 | P41594 | |
| ADPFSITPGIWVACI | 836 | Q16787 | |
| LPELSCKEGPLGWSS | 396 | Q9UGP4 | |
| FWLLCLIVGSSPEAP | 6 | Q2M2W7 | |
| SLCADILEWAGVVPP | 426 | Q9UNE0 | |
| TEADWVPLELCFGIP | 716 | Q658Y4 | |
| PCWSPEEESSLLPGF | 1106 | Q8ND23 | |
| VSCALWIPEVSIGCP | 276 | Q9NQC1 | |
| WGSENSVLIPEPVSC | 276 | A6NKB5 | |
| PALDSVGCPERITWL | 491 | Q9UMF0 | |
| EDWSISVELRPCPSG | 846 | Q7Z5P9 | |
| LGAWSLNATELDPCP | 71 | Q96PD5 | |
| NATCVEPTELTGWPI | 211 | Q8N7C0 | |
| PLELDTDGIWCVLPN | 856 | Q07864 | |
| CGSNSWTVVDIDPPL | 551 | P06213 | |
| SPECLWEEGKEVIPT | 296 | Q96JA3 | |
| LLPSAESPVCWLEQP | 331 | O95402 | |
| ELEVSCWPTLVILGP | 156 | Q8NBF2 | |
| DWDPQTGRLCIPSLS | 481 | Q9UHF4 | |
| LECEARGIPAPSLTW | 2031 | Q96RW7 | |
| LTCEASGIPLPSITW | 2406 | Q96RW7 | |
| IPSLDWLPASDGLVS | 726 | Q9Y2X0 | |
| LLSPLPGVWCFSELS | 26 | Q2VWP7 | |
| VTSSWCLFGPELPED | 136 | P06401 | |
| PDQGLLCDLLWSDPD | 196 | P62136 | |
| PTDVPDTGLLCDLLW | 191 | P62140 | |
| LECIASGVPTPDIAW | 266 | O94856 | |
| LSPPCSNWVETGLEV | 626 | B2RXH4 | |
| EPLALASGALPDWCE | 2051 | Q9ULT8 | |
| WTLTLALPREACGPL | 176 | A4D2P6 | |
| FLVWPKCGPISDTLL | 341 | Q9Y5R5 | |
| PSLPTEWALCGERED | 406 | O43909 | |
| VACWLLDPDSQEPTL | 1991 | O75417 | |
| SLTIPPCSEGVTWIL | 221 | P35219 | |
| WLLCEVSGFSPPNIL | 291 | P01880 | |
| GCLPQPEGTAWALDL | 91 | A8MZG2 | |
| ASVDLIGTCWPRSPA | 46 | P34998 | |
| DPPASLEVLSERCWG | 326 | P19235 | |
| LIGCLPPLFGWSSVE | 156 | Q8N6U8 | |
| WQLVEEIPEGCSTPD | 16 | Q86VF2 | |
| LDRLSCLDGTPPLSW | 271 | Q9NWZ3 | |
| LSPPCTLARSFGVEW | 211 | P09326 | |
| LACETSGAPRPAITW | 421 | Q58EX2 | |
| PFLWSPFESLCEIGE | 146 | P30260 | |
| EWSAPSDPLDILITG | 306 | Q8N6C8 | |
| SFDRPLWAEPCLGET | 896 | Q14114 | |
| LWAEPCLGETREPED | 901 | Q14114 | |
| ECEELKSCPWLSLPG | 271 | Q5THK1 | |
| LWPDVPLECIVSLGT | 646 | Q9NP80 | |
| PCVVVSGDLPITITW | 616 | O60469 | |
| NEWTLTPLALSGLCP | 186 | Q9Y4G2 | |
| CEDDITCGPTWLPLS | 126 | Q9BSG5 | |
| WLLDGQPCSSEFLPI | 401 | Q32P41 | |
| AVTPELCPDVTIWGV | 476 | Q8IYR2 | |
| APWCETIVGAFSLPD | 101 | O00204 | |
| VPETPLDCEVSLWSS | 271 | Q9BUD6 | |
| TSWDVPEDAVPCELL | 16 | Q9Y4C2 | |
| SLPAVLTLGSPEWEE | 456 | Q6ZUX3 | |
| EWSAPSDPLDILIAG | 306 | O75019 | |
| EWSAPSDPLDILIAG | 306 | Q8NHL6 | |
| ATVWTLGFAICSPLP | 161 | Q15761 | |
| GGDPLCIPELTWEQL | 236 | Q5JRX3 | |
| LAPEPEETWVAETLC | 76 | P0DUX0 | |
| LAPEPEETWVAETLC | 76 | P0DTA3 | |
| LAPEPEETWVAETLC | 76 | P0DUD1 | |
| FLWSLPVAPGACEAI | 111 | O95343 | |
| CIVPAWLPSLPDEVF | 376 | Q2M3G4 | |
| IPTGCLEVFPEAEWS | 756 | Q7Z7L1 | |
| GPPEGSLDVLQSWCE | 266 | P51692 | |
| DLSLLELEWPIQCPG | 261 | P22891 | |
| SCALWIPEVSIGSPE | 281 | Q6IE81 | |
| EILWDLPCSIMGSPL | 11 | Q96GD3 | |
| SPSCTLGLVLPLWSD | 156 | Q8TE77 | |
| GPPEGSLDVLQSWCE | 266 | P42229 | |
| LQAPLWPSSLGITDC | 476 | Q9UNK9 | |
| ESLSPSGCLLWDVPA | 201 | Q99941 | |
| LSLLSVTWVEEPCGP | 26 | Q8IZ52 | |
| DVDWTLATGPLLPSA | 156 | Q6ZRI6 | |
| PSLSTCQQGEDPLDW | 406 | Q6UXD7 | |
| PIPIISWCGSLDSRD | 256 | Q7Z4H8 | |
| SDLVFACLLPVWISP | 76 | P46094 | |
| TTIDPCWDISLDLPG | 506 | Q70EK9 | |
| TTIDPCWDISLDLPG | 221 | A6NNY8 | |
| LAPEPEETWVAETLC | 76 | P0DUX1 | |
| LAPEPEETWVAETLC | 76 | A0A494C0Z2 | |
| LAPEPEETWVAETLC | 76 | P0DUD3 | |
| LAPEPEETWVAETLC | 76 | P0DUD4 | |
| LAPEPEETWVAETLC | 76 | P0DUD2 | |
| LAPEPEETWVAETLC | 141 | A6NKU9 | |
| PEPEETWVAETLCGL | 216 | A6NKU9 | |
| APEPEETWVAETLCG | 361 | A6NKU9 | |
| SPCTLPSGEAGIIWD | 1401 | Q9H5I5 | |
| LCLPWLQEGSAFPTI | 16 | P01241 | |
| PDQGLLCDLLWSDPD | 196 | P36873 | |
| SEVLLGQLCSPEPDW | 96 | Q6UXR6 | |
| LPLPTSVACELWGQG | 1596 | A7E2V4 | |
| LAPEPEETWVAETLC | 76 | A0A494C191 | |
| PLDGTELCIWNTKDP | 46 | A2RRH5 | |
| EVSVPPGALDCWVFL | 346 | P48553 | |
| EEQPDWTLGCLSPES | 21 | P0DMS9 | |
| PLLPCLLGSWIEGFD | 536 | Q5TAX3 | |
| APWEPPCGLTESVEV | 116 | Q8NHX9 | |
| PSIPVGTCADWETRL | 91 | Q99676 | |
| GPLVCDETLQGILSW | 231 | O43240 | |
| LPASEAETVLCVWPG | 221 | Q2I0M4 | |
| CIVSGDPTPEISWLK | 1356 | Q5VTT5 |